22nd Century Group, Inc.

Equities

XXII

US90137F2020

Tobacco

Real-time Estimate Cboe BZX 01:54:50 2024-03-28 pm EDT 5-day change 1st Jan Change
0.121 USD -7.98% Intraday chart for 22nd Century Group, Inc. -6.12% -34.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Stocks Set for -2- DJ
Earnings Flash (XXII) 22ND CENTURY GROUP Reports Q4 Revenue $7.4M MT
22nd Century Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
22nd Century Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : 22nd Century Group, Inc. - Special Call
Specialty Acquisition Corporation completed the acquisition of Substantially all of GVB hemp/cannabis business from 22nd Century Group, Inc. and ESI Holdings, LLC for $3.1 million. CI
22Nd Century Group, Inc. Announces Termination of Peter Ferola as the Chief Legal Officer and Corporate Secretary CI
22nd Century Group Names Lawrence Firestone as Chair, Chief Executive MT
22Nd Century Group, Inc. Appoints Lawrence Firestone as Chief Executive Officer CI
22Nd Century Group, Inc. Appoints Lawrence Firestone as Chairman CI
22nd Century Group to Sell Hemp, Cannabis Business; Shares Rise After Hours MT
Specialty Acquisition Corporation entered into a equity purchase agreement to acquire Substantially all of GVB hemp/cannabis business from 22nd Century Group, Inc. and ESI Holdings, LLC for $2.3 million. CI
22nd Century Group, Inc. Continues VLN Expansion, Now Retailing in More Than 5,100 Stores CI
22nd Century Signs Additional Reduced Nicotine Content Technology License MT
22Nd Century Group, Inc. Expands Reduced Nicotine Content Tobacco IP with Latest Technology License CI
22Nd Century Remains 'Committed' to Exploring Wide Range of Alternatives CI
22nd Century Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (XXII) 22ND CENTURY GROUP Reports Q3 Revenue $17.8M MT
22Nd Century Group, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2023 CI
22nd Century Group Reduces Debt by Roughly $8.1 Million; Consummates $5.25 Million Public Offering MT
22nd Century Group, Inc. Announces to Reduce the Outstanding Principle of Its Senior Secured Credit Facility from Approximately $22.1 Million CI
Sector Update: Consumer Stocks Higher Late Afternoon MT
Sector Update: Consumer Stocks Advancing in Tuesday Afternoon Trading MT
22nd Century Group Prices $5.3 Million Public Offering of Shares, Warrants MT
22nd Century Group Plans Public Offering of Shares, Warrants MT
Chart 22nd Century Group, Inc.
More charts
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the consumer goods and pharmaceutical industries. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Sector
Tobacco
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.1315
Average target price
-
Consensus